NASDAQ
Emerald Health Therapeutics, Inc. (EMHTF) has a price/fcf ratio of -0.62x as of Tuesday, May 26, 2026. This represents a 47.50% decrease compared to its 12-month average of -0.42x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.